Srinagar: Dr Khalid Shah, a globally acclaimed cancer researcher from Kashmir, was honoured at SKIMS Soura during a CME & Research Orientation Programme organised by SKIMS-NAMS and the SKIMS Research Cell.
Dr Shah currently serves as Vice Chair of Research in the Department of Neurosurgery and Director of the Center for Stem Cell and Translational Immunotherapy at Brigham and Women’s Hospital, and is also a Professor at Harvard Medical School, Boston, USA.
Delivering a lecture titled ‘Role of Cellular and Gene Therapy in Brain Tumor Therapeutics’, Dr. Shah shed light on the latest innovations in brain tumor treatment, including advances in immunotherapies, engineered cell therapies, and precision medicine. He stressed the critical need for interdisciplinary collaboration and international partnerships in combating complex cancers like brain tumors.
“The battle against brain tumors demands a united, global approach—fusing cutting-edge research with clinical insights to develop life-saving therapies,” Dr Shah said, expressing his commitment to bringing global breakthroughs to benefit patients in Kashmir and beyond.
On the sidelines of the event, a key meeting was held between Dr Shah, SKIMS Director professor Ashraf Ghani, and senior faculty members to explore the creation of a collaborative research platform in cancer therapeutics. Discussions also focused on the long-term goal of establishing an ‘Integrated Cell and Gene Therapy Centre’ at SKIMS — a first-of-its-kind initiative in India aimed at revolutionizing cancer care.
The session concluded with an engaging Q&A, where participants deliberated on challenges in cancer research, funding avenues, and the need for international academic collaboration. Dr. Shah’s visionary address and his dream of giving back to his homeland received an overwhelmingly positive response from the medical fraternity and young researchers alike.
